Medline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
Follow MDLN
Alert me
Medline Inc. (MDLN) P/B ratio
As of 5 November 2026, Medline Inc. (MDLN) trades at a P/B ratio of 1.8×. Over the past ten years it has ranged from 0.0× (December 2025) to 2.1× (February 2026); the current reading is higher than 67% of that period. That is below the Medical Instruments & Supplies industry median of 2.3× and below the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.8× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 1.6× | (11.46%) |
| Jun 2026 | 1.8× | (5.94%) |
| Mar 2026 | 1.9× | 6.78% |
| Dec 2025 | 1.8× | — |
| 2 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| COO The Cooper Companies, Inc. compare | 1.5× |
| ALC Alcon compare | 1.7× |
| MDLN Medline Inc. | 1.8× |
| BAX Baxter International Inc. compare | 2.0× |
| BDX Becton, Dickinson and Company compare | 2.4× |
| SOLV Solventum Corporation compare | 3.1× |
| RMD ResMed Inc. compare | 5.7× |
| WST West Pharmaceutical Services, Inc. compare | 9.3× |
| ISRG Intuitive Surgical, Inc. compare | 10.1× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on MDLN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Book value per share
- The full statement